Global Pharma and Biotech Summit 2024: Innovation Under Pressure

At the Financial Times’ Global Pharma and Biotech Summit 2024, Christophe Weber, president and CEO, Takeda, discusses how trust and collaboration between the biopharma industry and stakeholders can be implemented to support successful healthcare transformation.

Leave a Reply

Your email address will not be published. Required fields are marked *